Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient with Opioid Use Disorder
Posterior Reversible Encephalopathy Syndrome (PRES) is a characteristic clinical radiographic syndrome with diffuse structural alteration of cerebral white matter secondary to myelin damage with diverse and multifactorial etiologies. It can present with acutely altered mentation, somnolence or occas...
Saved in:
Main Authors: | Terence Tumenta, Samuel Adeyemo, Oluwatoyin Oladeji, Oluwole Jegede, Bordes Laurent, Tolu Olupona |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2021/9999481 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Persistent Tachycardia in a Patient on Clozapine
by: Samuel Adeyemo, et al.
Published: (2020-01-01) -
Rituximab (monoclonal anti-CD20 antibody) induced posterior reversible encephalopathy syndrome (PRES): A case report and literature review
by: Praveen K. Sharma, MD, et al.
Published: (2025-03-01) -
Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
by: Luiz Carlos Porcello Marrone, et al.
Published: (2013-01-01) -
Posterior reversible encephalopathy syndrome related to severe hypomagnesaemia
by: Martín Naya Rosato, et al.
Published: (2025-01-01) -
Postpartum HELLP syndrome associated with posterior reversible encephalopathy syndrome
by: Rita Pinto Medeiros, et al.
Published: (2024-12-01)